Amgen names new head of research.THOUSAND OAKS, Calif.,--(BUSINESS WIRE)--May 8, 1997--Amgen (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :AMGN) Thursday announced that the company has named Dr. Lawrence M. Souza senior vice president of research. Dr. Souza previously served as vice president, molecular and cellular biology cellular biology n. The study of the molecular or chemical interactions of biological phenomena. . He succeeds Daniel Vapnek, who announced his retirement last June. Dr. Souza has been with Amgen since 1981 and has served as director, exploratory programs and has been responsible for the discovery of new product candidates with a focus on molecular, developmental and experimental biology. He was instrumental in the discovery and cloning of NEUPOGEN (R) (Filgrastim, G-CSF G-CSF granulocyte colony-stimulating factor. G-CSF granulocyte-colony stimulating factor. G-CSF Granulocyte colony-stimulating factor Molecular therapeutics A biological response modifier, the recombinant DNA form of ), one of Amgen's two breakthrough products. More recently, Dr. Souza has led Amgen's efforts in genomic discovery, including the identification in recent weeks of molecules that hold promise in cancer, osteoporosis and other chronic conditions. "Larry has led several of Amgen's most significant drug discovery initiatives, including the discovery of NEUPOGEN, and our very exciting current work in genomics. He is the ideal choice to lead Amgen's research efforts into the 21st century," said Gordon Binder, chairman and chief executive officer. Dr. Souza received his bachelor's degree in 1975 from the University of California, Berkeley The University of California, Berkeley is a public research university located in Berkeley, California, United States. Commonly referred to as UC Berkeley, Berkeley and Cal . He later received his doctorate in molecular biology molecular biology, scientific study of the molecular basis of life processes, including cellular respiration, excretion, and reproduction. The term molecular biology was coined in 1938 by Warren Weaver, then director of the natural sciences program at the Rockefeller from the University of California, Los Angeles UCLA comprises the College of Letters and Science (the primary undergraduate college), seven professional schools, and five professional Health Science schools. Since 2001, UCLA has enrolled over 33,000 total students, and that number is steadily rising. , where he also received his postdoctoral fellowship in microbiology and immunology. Amgen is a global biotechnology company that discovers, develops, manufactures and markets human therapeutics based on advances in cellular and molecular biology. CONTACT: Amgen, Thousand Oaks David Kaye, 805/447-6692 (media) Denise Powell, 805/447-4346 (investors) |
|
|||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion